Search Count: 19
 |
Human Tnf-Alpha In Complex With 2-[5-(3-Chloro-4-{[(1R)-1-(2-Fluorophenyl)Ethyl]Amino}Quinolin-6-Yl)Pyrimidin-2-Yl]Propan-2-Ol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2020-12-09 Classification: CYTOKINE Ligands: VGY, GOL |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-29 A.K.A 7-(1,2-Diphenylethyl)-1H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: CL, CA, NAG, HEC, UEY, MAN |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-40 A.K.A 7-[(1R)-1-Phenyl-3-{[(1R,4R)-4-Phenylcyclohexyl]Amino}Propyl]-3H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: HEC, NAG, CA, CL, UFA |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-37 A.K.A 7-(1-Phenyl-3-(((1S,3S)-3-Phenyl-2,3-Dihydro-1H-Inden-1-Yl)Amino)Propyl)-1H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: HEC, CL, CA, UF7, NAG |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-41 A.K.A 7-[1-Phenyl-3-({4-Phenylbicyclo[2.2.2]Octan-1-Yl}Amino)Propyl]-3H-[1,2,3]Triazolo[4,5-B]Pyridin-5-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: CL, HEC, NAG, CA, UFD |
 |
Crystal Structure Of Myeloperoxidase Subform C (Mpo) Complex With Compound-12 (Aka; 7-Benzyl-1H-[1,2,3]Triazolo[4,5-B]Pyrid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2020-10-14 Classification: OXIDOREDUCTASE Ligands: CL, NAG, FUC, HEC, BMA, MAN, 7GD, CA |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2016-05-11 Classification: TRANSFERASE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2016-05-11 Classification: TRANSFERASE Ligands: GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2016-05-11 Classification: TRANSFERASE Ligands: GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2016-05-11 Classification: TRANSFERASE Ligands: GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: STU, GOL |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) In Complex With Staurosporine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: STU, GOL |
 |
Tgf-Beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A,R495A) In Complex With Staurosporine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: STU |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D) In Complex With 3-Amino-6-[4-(2-Hydroxyethyl)Phenyl]-N-[4-(Morpholin-4-Yl)Pyridin-3-Yl]Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5L4 |
 |
Tgf-Beta Receptor Type 1 Kinase Domain (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) In Complex With 3-Amino-6- [4-(2-Hydroxyethyl)Phenyl]-N-[4-(Morpholin-4-Yl)Pyridin-3-Yl]Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5L4 |
 |
Tgf-Beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A,R495A) In Complex With 3-Amino-6-[4-(2- Hydroxyethyl)Phenyl]-N-[4-(Morpholin-4-Yl)Pyridin-3-Yl] Pyrazine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5L4 |
 |
Tgf-Beta Receptor Type 2 Kinase Domain (E431A,R433A,E485A,K488A,R493A,R495A) In Complex With Amppnp
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ANP, MG |
 |
Crystal Structure Of Beta-Site App-Cleaving Enzyme 1 (Bace-Wt) Complex With Bms-655295 Aka N~3~-((1S,2R)-1- Benzyl-2-Hydroxy-3-((3-Methoxybenzyl)Amino)Propyl)-N~1~, N~1~-Dibutyl-1H-Indole-1,3-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2011-04-06 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 3HF, IOD, GOL |
 |
Crystal Structure Of Beta-Site App-Cleaving Enzyme 1 (Bace-Wt) Complex With Bms-681889 Aka N~1~-Butyl-5-Cyano- N~3~-((1S,2R)-1-(3,5-Difluorobenzyl)-2-Hydroxy-3-((3- Methoxybenzyl)Amino)Propyl)-N~1~-Methyl-1H-Indole-1,3- Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2011-04-06 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 3HH, SO4, GOL |